These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 24376083)
1. Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. Jeppesen DK; Nawrocki A; Jensen SG; Thorsen K; Whitehead B; Howard KA; Dyrskjøt L; Ørntoft TF; Larsen MR; Ostenfeld MS Proteomics; 2014 Mar; 14(6):699-712. PubMed ID: 24376083 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Chaffer CL; Brennan JP; Slavin JL; Blick T; Thompson EW; Williams ED Cancer Res; 2006 Dec; 66(23):11271-8. PubMed ID: 17145872 [TBL] [Abstract][Full Text] [Related]
3. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer. Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865 [TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Differential Proteome Expression in Epithelial-to-Mesenchymal Transition of Bladder Epithelial Cells Using SILAC Method. Yang G; Lu W; Yu D; Sun C; Guo J; Li Z; Guan F Molecules; 2016 Jan; 21(1):84. PubMed ID: 26784156 [TBL] [Abstract][Full Text] [Related]
5. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer. Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251 [TBL] [Abstract][Full Text] [Related]
6. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Ji H; Greening DW; Barnes TW; Lim JW; Tauro BJ; Rai A; Xu R; Adda C; Mathivanan S; Zhao W; Xue Y; Xu T; Zhu HJ; Simpson RJ Proteomics; 2013 May; 13(10-11):1672-86. PubMed ID: 23585443 [TBL] [Abstract][Full Text] [Related]
7. Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state. Garnier D; Magnus N; Meehan B; Kislinger T; Rak J Exp Cell Res; 2013 Oct; 319(17):2747-57. PubMed ID: 23954818 [TBL] [Abstract][Full Text] [Related]
8. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Lazar I; Clement E; Ducoux-Petit M; Denat L; Soldan V; Dauvillier S; Balor S; Burlet-Schiltz O; Larue L; Muller C; Nieto L Pigment Cell Melanoma Res; 2015 Jul; 28(4):464-75. PubMed ID: 25950383 [TBL] [Abstract][Full Text] [Related]
9. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells. Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635 [TBL] [Abstract][Full Text] [Related]
10. Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells. Huang CS; Ho JY; Chiang JH; Yu CP; Yu DS Cells; 2020 Jun; 9(6):. PubMed ID: 32517366 [TBL] [Abstract][Full Text] [Related]
11. Proteomic Profiling of Exosomes Secreted by Breast Cancer Cells with Varying Metastatic Potential. Gangoda L; Liem M; Ang CS; Keerthikumar S; Adda CG; Parker BS; Mathivanan S Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 29115712 [TBL] [Abstract][Full Text] [Related]
12. Hypoxic exosomes facilitate bladder tumor growth and development through transferring long non-coding RNA-UCA1. Xue M; Chen W; Xiang A; Wang R; Chen H; Pan J; Pang H; An H; Wang X; Hou H; Li X Mol Cancer; 2017 Aug; 16(1):143. PubMed ID: 28841829 [TBL] [Abstract][Full Text] [Related]
13. Profiling the evolution of human metastatic bladder cancer. Nicholson BE; Frierson HF; Conaway MR; Seraj JM; Harding MA; Hampton GM; Theodorescu D Cancer Res; 2004 Nov; 64(21):7813-21. PubMed ID: 15520187 [TBL] [Abstract][Full Text] [Related]
14. In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome. Sinha A; Ignatchenko V; Ignatchenko A; Mejia-Guerrero S; Kislinger T Biochem Biophys Res Commun; 2014 Mar; 445(4):694-701. PubMed ID: 24434149 [TBL] [Abstract][Full Text] [Related]
15. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway. Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914 [TBL] [Abstract][Full Text] [Related]
16. Emerging roles of exosomes during epithelial-mesenchymal transition and cancer progression. Greening DW; Gopal SK; Mathias RA; Liu L; Sheng J; Zhu HJ; Simpson RJ Semin Cell Dev Biol; 2015 Apr; 40():60-71. PubMed ID: 25721809 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the roles of exosomes in colorectal cancer liver metastasis. Wang X; Ding X; Nan L; Wang Y; Wang J; Yan Z; Zhang W; Sun J; Zhu W; Ni B; Dong S; Yu L Oncol Rep; 2015 May; 33(5):2445-53. PubMed ID: 25760247 [TBL] [Abstract][Full Text] [Related]
19. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro. Yang L; Wu XH; Wang D; Luo CL; Chen LX Mol Med Rep; 2013 Oct; 8(4):1272-8. PubMed ID: 23969721 [TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Proteomics Analysis Reveals a Secretory Path- and Status-Dependent Signature of Exosomes Released from Tumor-Associated Macrophages. Zhu Y; Chen X; Pan Q; Wang Y; Su S; Jiang C; Li Y; Xu N; Wu L; Lou X; Liu S J Proteome Res; 2015 Oct; 14(10):4319-31. PubMed ID: 26312558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]